Tunneling nanotubes: a new dimension of intercellular communication and recent progress Authors: Xinyu Dong, Yan Xuan, Muning Wang, Siyao Chang, Xuesong Hu, Zhiyang Han Published: 2026 ABSTRACT AbstractCommunication between cells can occur over long distances through the diffusion of soluble mediators and the delivery of extracellular vesicles (EVs), and over short distances through contact-dependent junctional structures formed between adjacent cells. Recent studies on tunneling nanotubes (TNTs) suggest that, in certain systems, cells may engage in relatively direct material exchange that does not rely on diffusion or stochastic uptake. TNTs typically appear as thin, bridge-like membranous protrusions spanning intercellular gaps. They are supported by F-actin and may incorporate microtubules, thereby enabling intercellular transfer ranging from ions and small signaling molecules to RNA, protein complexes, and even organelles. A major challenge in the field, however, is the lack of unified definitions and evidentiary standards. The absence of universal specific markers, the fragility of these structures, and the limitations of static two-dimensional imaging make TNTs prone to confusion with filopodia or cytonemes, cytokinetic bridges, apparent transfer arising from EV deposition or uptake, and tumor microtubes (TMs), which undermines functional attribution and cross-study comparability. Guided by a minimum evidence set, this review proposes a reproducible identification workflow, systematically summarizes TNT structural heterogeneity, including thin versus thick TNTs and open versus closed termini or gap junction-like contacts, and relates these features to transport capacity and transport modalities. We also stratify disease-associated findings by strength of evidence to distinguish areas of consensus from ongoing controversies. We further highlight the double-edged nature of TNTs: they may support metabolic rescue and tissue repair through organelle sharing, yet they can also be exploited by pathogens, tumors, and pathogenic aggregates to facilitate stealthy spread, therapeutic tolerance, and pathological propagation. Finally, we summarize current intervention entry points and their limitations, and argue that future work should build on in vivo dynamic evidence, incorporate controls that distinguish TNT-mediated transfer from vesicle-based routes, and pursue cell-type-specific mechanistic dissection to establish a more robust chain of evidence. Such efforts may enable the identification and mitigation of disease-associated detrimental TNT activities while preserving physiological roles, thereby informing feasibility assessment and early validation for clinical translation.Keywords: Tunneling nanotubes, Intercellular communication, Cell–cell connections, Intercellular transfer, Disease mechanisms, Translational intervention Introduction Communication between cells is essential for tissue homeostasis, coordinated development, and adaptive responses to stress. This communication can occur through several mechanistically distinct routes. Cells separated by distance can exchange information through soluble mediators, such as cytokines and growth factors, which diffuse through the extracellular space and activate receptors on target cells. Long-range signaling can also be mediated by extracellular vesicles (EVs), which carry proteins, lipids, and nucleic acids and modulate recipient cell function after release and uptake [1]. In contrast, neighboring cells often rely on contact-dependent communication. Connexin-based gap junctions (GJs) form intercellular channels between adjacent membranes, permitting the passage of ions and small hydrophilic molecules and thereby enabling electrical and metabolic coupling [2]. Synaptic communication is another specialized form of local contact-dependent signaling, in which neurotransmitter release across a narrow intercellular cleft enables rapid and spatially restricted signal transmission [3]. Against this backdrop, increasing attention has turned to an additional, potentially complementary mechanism: whether cells can establish direct, long-distance membranous conduits that support material transfer without relying solely on diffusion or vesicle release and uptake. In this context, tunneling nanotubes (TNTs) have attracted growing interest as membranous intercellular connections that may provide relatively direct routes for material exchange between cells. In the seminal study by Rustom et al., nanotubular connections between PC12 cells were shown to support intercellular organelle transport, introducing the concept of “nanotubular highways” for long-range cell-to-cell communication [4]. In the same year, Önfelt et al. reported membrane nanotubes connecting immune cells, including natural killer cells and the murine J774 macrophage cell line, further supporting the existence of nanotube-mediated communication beyond neuronal-like cell models [5]. Subsequent studies have reported TNTs or TNT-like structures across diverse cell types and tissue contexts, suggesting that these structures are not merely artifacts of in vitro culture. Morphologically, TNTs are typically described as thin membranous connections spanning intercellular gaps, with reported diameters ranging from tens of nanometers to the micrometer scale and lengths from several micrometers to more than 100 μm, depending on cell type and imaging method. TNTs commonly contain cytoskeletal elements, particularly filamentous actin (F-actin) and, in some thicker structures, microtubules, which provide structural support and tracks for directional cargo movement. Reported cargos include ions, proteins, RNA species, vesicles, and organelles such as mitochondria and lysosome-related compartments [6]. Accordingly, TNTs have been implicated in both physiological adaptation and disease-associated processes, but their interpretation requires careful attention to structural validation and route-resolved transfer evidence. However, the biological roles of TNTs are more complex than their morphology alone suggests and display a clear duality. On one hand, TNT-mediated exchange of organelles and other cellular components may help stressed or injured cells restore bioenergetic function and mitigate stress responses. For example, mitochondrial transfer via TNTs has been reported to rescue apoptotic PC12 cells, supporting a potential protective role under cellular stress [7]. On the other hand, TNTs may be exploited in pathological settings. Viruses can use TNTs or TNT-like structures for long-distance cell-to-cell spread [8], and malignant cells may use TNT-mediated intercellular exchange to redistribute cellular contents and, under chemotherapeutic stress, promote drug redistribution or treatment-tolerant phenotypes [9, 10]. Thus, TNTs provide an important entry point for dissecting disease mechanisms, although their translational targeting remains exploratory and requires more selective tools and stronger disease-relevant evidence. This review first outlines the structural features and physiological roles of TNTs, clarifies operational criteria for their identification, and summarizes major confounders that commonly lead to misclassification in experimental settings. We place particular emphasis on the need to distinguish morphology-only observations from route-resolved cargo transfer and functional evidence, and use a minimum evidence framework to guide interpretation across different experimental systems. We then discuss TNTs in disease contexts, focusing on key findings in infection, neurodegeneration, and cancer, while distinguishing conclusions supported by relatively strong evidence from those that remain controversial. Finally, we consider potential intervention entry points and major limitations in light of current technical capabilities, providing a roadmap for subsequent mechanistic studies and cautious translational exploration. Definition, identification, and common confounders Core concept and defining features TNTs are generally described as thin, membrane-enclosed intercellular bridges that can provide a relatively direct route for material exchange between cells [6]. Although definitions vary across studies, recurring operational features include: (i) a slender membranous bridge connecting two cells, (ii) a suspended or non-substrate-adherent configuration, ideally confirmed by z-stack or three-dimensional imaging, and (iii) evidence supporting membrane continuity and/or cargo movement along the connection [11, 12]. Reported dimensions vary widely across experimental systems, ranging from tens of nanometers to the micrometer scale in diameter and from several micrometers to more than 100 μm in length, depending on cell type, culture conditions, and imaging method [6]. Structurally, TNTs are commonly rich in F-actin, whereas subsets of thicker TNTs may also contain microtubules, a difference that is likely related to transport capacity and cargo type [13, 14]. A central limitation of the field is the absence of universal, TNT-specific markers. Together with the fragility of these structures and the limitations of static two-dimensional (2D) imaging, this increases both false negatives, such as loss during fixation, and false positives, such as misclassification of other protrusions or residual intercellular bridges as TNTs [6, 12]. In addition, terminal architecture is not uniform across systems: some connections appear consistent with open cytoplasmic continuity, whereas others may exhibit closed ends or gap junction (GJ)-like contacts [15]. These factors contribute to heterogeneous nomenclature and uneven evidentiary thresholds in the literature, ranging from morphology-only assignments to functional validation using live-cell tracking, fluorescence recovery after photobleaching (FRAP), or photoconversion. Accordingly, we designate morphologically similar but insufficiently validated connections as TNT-like (Sect. “TNT-like structures”), benchmark them against frequent look-alikes (Sect. “Cytokinetic bridges”), discuss EV-related sources of apparent “pseudo-transfer” (Sect.' “TNTs and EVs”), and clarify boundaries between TNTs and tumor microtubes in cancer contexts (Sect. “TNTs versus tumor microtubes”), with the aim of reducing misclassification and improving cross-study comparability. TNT-like structures TNT-like refers to thin, tubular, or bridge-shaped intercellular connections that resemble TNTs by microscopy but lack sufficient evidence for rigorous classification. This distinction is practical rather than semantic: many thin “intercellular lines” may arise from alternative biological processes or technical contingencies, including substrate-adherent protrusions, membrane tethers generated during migration, residual bridges during late cytokinesis, or processes coupled to EV deposition or uptake, phagocytosis, or cell fusion, each of which can produce an appearance of intercellular transfer [11, 16]. Without route-resolving controls, labeling such structures as TNTs risks overinterpretation and undermines comparability across studies. Thus, when a thin connection is observed but live-cell evidence does not demonstrate cargo movement along the connection into recipient cells, or when major confounders, such as EV routes, phagocytosis, or fusion, cannot be excluded, TNT-like provides a more defensible descriptor. Likewise, when key information is incomplete—membrane continuity at termini, a truly suspended configuration, or the presence of a defined cytoskeletal scaffold—the TNT label should be deferred. Importantly, TNT-like does not imply lack of biological relevance; it is a conservative statement about evidentiary strength and highlights where additional discrimination is required. In later sections, we stratify evidence using a minimum evidence set framework (Fig. 1) to separate morphological resemblance from functional validation across systems and disease settings. Standardized decision workflow for identifying TNTs Distinguishing TNTs from look-alikes: filopodia, cytonemes, and cytokinetic bridges Thin protrusions and intercellular “lines” are frequently encountered in routine imaging and can be difficult to classify on morphology alone. TNTs are particularly prone to misassignment because they lack universal specific markers, can resemble other actin-rich protrusions in static 2D images, and are easily deformed or disrupted during fixation and sample preparation [6, 11, 12]. Therefore, TNT identification should not rely solely on the presence of a thin connection between cells, but should also consider formation context, substrate adherence, cell-cycle status, cytoskeletal composition, three-dimensional configuration, and evidence of cargo movement along the connection. Filopodia Filopodia are finger-like, F-actin-supported protrusions involved in environmental sensing, adhesion, migration, and local cell–cell or cell–matrix interactions [17–19]. Because filopodia and TNTs can both appear as thin actin-rich protrusions, morphology alone is insufficient for discrimination. A practical distinction is that filopodia are typically substrate-oriented or locally exploratory protrusions, whereas TNTs, in stricter usage, are suspended intercellular bridges for which route-resolved transfer along the connection can be demonstrated. Therefore, the key distinction from TNTs is not merely “thinness”, but formation context, substrate adherence, three-dimensional configuration, and evidence of intercellular cargo movement [11, 12]. Mechanistically, filopodia and TNTs can share actin regulators but do not necessarily use them in the same way. In neuronal-like cells, a filopodia-promoting module involving cell division control protein 42 homolog (CDC42), insulin receptor substrate protein 53 (IRSp53), and vasodilator-stimulated phosphoprotein (VASP) has been reported to antagonize TNT formation, whereas epidermal growth factor receptor kinase substrate 8 (Eps8) can bias protrusive activity toward TNT formation and support TNT-mediated vesicle transfer [20]. However, this relationship should not be generalized across all cell types. For example, CDC42 has been implicated in TNT formation or TNT-like intercellular bridge formation in other systems, including senescent cells, where mechanistic target of rapamycin (mTOR) and CDC42 signaling were required for mitochondrial transfer through cytoskeleton-supported intercellular bridges [21]. Thus, actin-regulatory differences between filopodia and TNTs are best interpreted in a cell-type- and context-dependent manner. When only planar images are available and transport evidence is lacking, classification as TNT-like is the more conservative choice. Cytonemes Cytonemes are thin, actin-rich protrusions that mediate contact-dependent delivery of signaling ligands, particularly during developmental patterning. They are often conceptualized as specialized filopodia that extend from signal-producing or signal-receiving cells and establish contact with distant target cells [22–24]. Experimental work on Wnt signaling has further shown that actin-based filopodia can transport Wnt ligands to responding cells, supporting the role of cytoneme-like protrusions in spatially controlled signaling [25]. Because cytonemes and TNTs can both appear as thin, F-actin-supported intercellular structures, morphology alone is insufficient for classification. A practical distinction is evidentiary: cytonemes are primarily defined by directed ligand delivery or signal presentation at distal contact sites, whereas TNTs, in stricter usage, imply a suspended conduit with evidence that cellular contents or cargo move along the connection into recipient cells [11, 24]. Where data primarily support ligand delivery or signal presentation at the protrusion tip or contact site, cytoneme is the more appropriate term; where cargo movement along a suspended intercellular connection into recipient cells is observed and major confounders are excluded, the TNT designation is more strongly supported. Cytokinetic bridges Cytokinetic bridges are intercellular bridges formed between daughter cells during late cytokinesis. They typically contain a midbody-associated structure that organizes the abscission machinery and are ultimately resolved when the bridge is severed during abscission [26, 27]. Because these bridges can appear as narrow intercellular “lines” in static images, they should be actively excluded before assigning TNT identity. Unlike TNTs, cytokinetic bridges are defined by their cell-division history: they arise after cleavage furrow ingression, connect recently divided sister cells, often contain a midbody or midbody remnant, and progress toward abscission. Time-lapse imaging therefore provides the most direct discrimination. If the connection emerges during cytokinesis, lies along the midline between daughter cells, contains a midbody-associated structure, and progresses toward abscission, it is more consistent with a cytokinetic bridge than with a TNT. Although some cytokinetic bridges can be long-lived in specific developmental contexts, persistence alone should not be used to classify a structure as a TNT [28]. Collectively, filopodia, cytonemes, and cytokinetic bridges can all mimic TNTs in static imaging but differ in formation context, functional implication, and evidentiary requirements. When evidence is limited to morphology, TNT-like terminology, together with live-cell tracking and route-resolving controls, provides a pathway to progressively strengthen classification while minimizing terminological drift. TNTs and EVs TNTs and EVs represent distinct but potentially coexisting routes of intercellular communication. EVs are extracellular lipid bilayer-enclosed particles that carry proteins, lipids, and nucleic acids and can modulate recipient cells after release and uptake [1, 16]. In contrast, TNTs are membrane-connected intercellular bridges that may support direct cargo movement along a physical connection between cells [6]. Because both routes can produce similar readouts, such as fluorescent material appearing in recipient cells, TNT-mediated transfer should not be inferred from recipient-cell signal alone. EV-related and migration-associated vesicular processes are also major sources of confounding in TNT studies. Migrasomes provide a particularly relevant example: they are migration-dependent vesicular organelles that form on the tips or intersections of retraction fibers and may subsequently be released into the extracellular space or taken up by surrounding cells [29]. Because migrasomes are coupled to retraction fibers and cell movement, they can resemble TNT-like termini, vesicular swellings, or budding events in static images unless their formation dynamics, migration dependence, and characteristic vesicular morphology are considered. Similarly, punctate signals observed along or near a thin intercellular connection may represent cargo moving within a TNT, EVs adhering to the outer membrane, EV deposition followed by uptake, or vesicles associated with retraction fibers. Because EVs are pervasive in most culture systems, fluorescence or “cargo” signals in recipient cells do not, by themselves, demonstrate TNT-mediated entry. EV field guidelines emphasize the need for careful characterization, functional controls, and avoidance of over-attribution when assigning biological activity to a specific EV-associated route [16]. By analogy, TNT studies should combine live-cell imaging of cargo movement along a suspended connection, three-dimensional validation of bridge geometry, controls for EV release and uptake, and exclusion of phagocytosis or cell fusion. These controls are essential for distinguishing route-resolved TNT-mediated transfer from EV-mediated or migration-associated pseudo-transfer. TNTs versus tumor microtubes In cancer biology, particularly in glioblastoma, it is important to distinguish TNTs from tumor microtubes (TMs), although the terminology may overlap in some studies. TMs were originally characterized in astrocytic brain tumors as ultra-long, neurite-like tumor cell protrusions that extend through brain tissue, interconnect tumor cells over long distances, and contribute to a multicellular network associated with invasion, proliferation, network repair, treatment resistance, and connexin 43 (Cx43)-mediated gap junction coupling [30, 31]. In contrast, TNTs are usually defined more broadly as thin, membrane-enclosed intercellular bridges that span intercellular gaps and, in stricter usage, require evidence that cargo moves along the connection into recipient cells [4–6]. Several morphological and contextual features may therefore help distinguish these structures. TNTs are commonly described as suspended, non-substrate-adherent bridges connecting two cells, whereas TMs are more often tissue-embedded tumor cell protrusions that extend within the brain parenchyma and form relatively stable, large-scale networks. TNT identification emphasizes membrane continuity, a free intercellular span, and route-resolved cargo transfer, while TM studies emphasize invasive protrusive morphology, network topology, and functional coupling through gap junctions. TNTs may mediate transfer of vesicles, proteins, RNA, ions, and organelles depending on their architecture, whereas TMs are most strongly supported as network structures for electrical or small-molecule coupling and collective tumor cell resistance; whether they function as open conduits for large-cargo exchange should be evaluated case by case. Therefore, TNTs and TMs should not be treated as interchangeable terms. A thin connection between tumor cells should be classified according to the experimental context and evidence type: suspended conduit-like bridges with route-resolved cargo transfer are more consistent with TNTs, whereas stable, tissue-embedded, network-forming protrusions in glioma models are more consistent with TMs. When morphology is similar but the evidence is insufficient to establish either category, the more conservative term “TNT-like structure” should be used, and additional three-dimensional imaging, live-cell tracking, cytoskeletal characterization, and functional coupling assays should be performed. Structural and functional features of tunneling nanotubes Size and structural heterogeneity As a form of direct intercellular communication, TNTs exhibit pronounced morphological heterogeneity. This heterogeneity is reflected not only in their dimensions but also in their cytoskeletal composition and, consequently, in their functional properties [6]. Across experimental systems, reported TNTs vary widely in diameter, length, and internal architecture, and these differences provide a physical basis for functional diversity [6, 32]. A commonly cited distinction between thin and thick TNTs was shaped in part by studies of membrane nanotubes in macrophages, in which two structurally and functionally different classes were described. Thin nanotubes were reported to contain mainly F-actin, whereas thicker nanotubes, particularly those exceeding approximately 0.7 μm in diameter, contained both F-actin and microtubules and supported long-distance vesicular traffic [14]. This classification has been useful for linking nanotube diameter and cytoskeletal composition to transport capacity. In general, thinner nanotubular connections are more often associated with the movement of small molecules, surface-associated particles, or small vesicular cargo, whereas thicker structures are more compatible with the transport of larger vesicular or organellar cargo [33]. However, the thin-versus-thick distinction should be regarded as an operational framework rather than a universally adopted taxonomy. TNT dimensions and cytoskeletal composition vary substantially across cell types, culture conditions, imaging methods, and disease models. In many studies, TNTs are classified using different diameter thresholds or are described without a strict thin/thick subdivision. Therefore, although the thin/thick framework provides a useful way to discuss structure–function relationships, TNT classification should be interpreted in a context-dependent manner and supported by direct evidence of cytoskeletal architecture and cargo transport whenever possible. More recently, high-resolution correlative imaging has revealed an additional level of structural complexity represented by individual tunneling nanotubes (iTNTs). In neuronal cell models, structures that appeared as single TNTs under fluorescence microscopy were shown by correlative cryo-electron microscopy and focused ion beam-scanning electron microscopy (FIB-SEM) to consist of bundles of individual membrane nanotubes. Each iTNT was delimited by its own plasma membrane, appeared to be open-ended, and contained highly organized bundles of parallel actin filaments; membrane-bound compartments and mitochondria were also observed within these structures [34]. This observation suggests that at least some TNTs identified by conventional light microscopy may represent composite nanotubular bundles rather than single uniform conduits. The iTNT concept therefore reinforces the need for three-dimensional and ultrastructural validation when defining TNT architecture. However, because these findings were obtained primarily in neuronal cell systems, whether iTNT organization is a general feature across cell types or a context-specific structural subtype remains to be determined. Terminal architecture The ultrastructure at TNT termini is a key determinant of how these connections mediate communication. In many models, TNTs have been conceptualized as open-ended membranous conduits that provide cytoplasmic continuity between connected cells, thereby allowing transfer of small solutes and, together with cytoskeleton- and motor-dependent transport, movement of larger cargo such as vesicles or organelles [15]. However, high-resolution imaging and tissue-based studies indicate that terminal architecture is not uniform across systems. Some TNTs or TNT-like structures may instead form closed-ended contacts or specialized junctional interfaces, suggesting that not all TNT-related connections function as fully open conduits for bulk cytoplasmic exchange [35, 36]. A notable example has been described in the retina, where pericyte-associated interpericyte TNTs connect distant pericytes and participate in neurovascular coupling. These structures were reported to contain mitochondria within the nanotubular segment and to communicate with neighboring pericyte processes through Cx43-mediated gap junctions [36]. Such semi-open or junction-coupled arrangements broaden the functional interpretation of TNT-related structures. Rather than serving exclusively as conduits for bulk material transfer, they may also act as platforms for electrochemical coupling, including calcium signal coordination, while mitochondria positioned within the nanotubular segment may help meet local energy demands. These findings emphasize that TNT termini should be assessed directly, because open continuity, closed apposition, and gap junction-coupled contacts imply different mechanisms of intercellular communication. Cytoskeletal architecture and transport dynamics Cytoskeletal organization is a central determinant of TNT stability, geometry, and transport capacity. Current evidence supports a continuum in which TNTs range from predominantly F-actin-rich structures to composite nanotubes containing both F-actin and microtubules [13, 14]. Linear F-actin polymerization contributes to TNT initiation and elongation, and Eps8/IRSp53-dependent actin remodeling has been shown to drive TNT formation in neuronal-like cells [13]. In macrophage membrane nanotubes, thinner nanotubes were reported to contain mainly F-actin, whereas thicker nanotubes, particularly those exceeding approximately 0.7 μm, contained both F-actin and microtubules and supported long-distance vesicular traffic [14]. Actin-based motor systems can also contribute to TNT formation and cargo transfer. For example, myosin X has been shown to be essential for human immunodeficiency virus type 1 (HIV-1) Nef accessory protein-induced TNT formation and intercellular Nef transfer between macrophages and T cells [37]. These findings support the view that actin-rich TNTs can mediate specialized cargo movement, although the specific motor requirements may vary with cell type and cargo identity. Microtubule-containing TNTs appear more compatible with higher-capacity and longer-range transport. In B lymphocyte and B-lymphoma cell systems, TNT networks have been linked to transport properties and bidirectional mitochondrial transfer, with evidence that microtubule-associated kinesin and actin-associated myosin VI can cooperate during mitochondrial movement through nanotubes [33, 38]. Thus, TNT cytoskeletal composition should not be viewed as a fixed structural feature. Rather, it defines context-dependent transport regimes, ranging from localized F-actin- and myosin-associated exchange to composite actin–microtubule architectures that support larger vesicular or organellar cargo. Dynamics and lifetime TNTs are highly dynamic structures whose formation, remodeling, and disappearance can occur over short timescales. Their apparent lifetime varies with cell type, cellular stress, substrate and matrix conditions, mechanical tension, and imaging parameters [6]. During their lifespan, TNTs may elongate, retract, thicken, thin, or undergo local remodeling, indicating that they should be interpreted as dynamic membrane–cytoskeletal structures rather than static tubes [39]. In live pancreatic ductal adenocarcinoma cell models, scanning ion conductance microscopy (SICM) and scanning electrochemical microscopy (SECM) have been used to visualize TNT formation, elongation, cleavage, mitochondrial transfer, and associated changes in intracellular reactive oxygen species (ROS), illustrating how real-time imaging can link structural dynamics with functional readouts [39]. The frequently described “beads-on-a-string” appearance should also be interpreted cautiously. Rather than necessarily indicating fragmentation or degeneration, bead-like morphology may reflect cargo or organelle movement, local membrane heterogeneity, membrane–protein interactions, membrane composition, or tension-dependent remodeling along the nanotube [40]. Therefore, bead-like structures along a TNT should not be taken as direct evidence of breakage unless supported by time-resolved imaging showing discontinuity, retraction, or loss of membrane integrity. Experimental observations suggest that TNTs can persist from minutes to hours depending on the system. In developing neuron–astrocyte co-cultures, transient nanotubes were reported to mediate electrical coupling and calcium signaling between distant cells [41]. In developmental models, including zebrafish embryos, TNT-like connections have also been observed in vivo and shown to support intercellular transfer, emphasizing that TNT dynamics are not restricted to conventional 2D culture systems [42]. Under stress conditions, including chemotherapeutic pressure, TNT abundance and persistence may change, but increased TNT number should not automatically be interpreted as increased stability or stronger functional transfer [10]. Prolonged illumination, phototoxicity, fixation, and mechanical disturbance can further distort TNT morphology or accelerate breakage; therefore, TNT lifetime should always be interpreted in light of the imaging modality and experimental handling conditions [6]. Limitations of 2D culture and evidence from three-dimensional and in vivo systems Conventional 2D cell culture has clear limitations for studying TNTs because it does not fully recapitulate the three-dimensional (3D) extracellular matrix (ECM) architecture, spatial constraints, mechanical forces, and chemical gradients experienced by cells in tissues. On flat substrates, cells spread differently and encounter simplified adhesive and mechanical cues, which may influence TNT frequency, morphology, orientation, and apparent function. Therefore, TNTs observed in 2D settings should not be assumed to fully reflect their native organization or stability. Recent work has begun to examine TNT-like connections in 3D or ECM-mimicking environments. In fibrous ECM-mimicking scaffolds, changes in fiber alignment and network architecture were shown to alter cell shape, migration behavior, and TNT characteristics. For example, aligned fibers can promote elongated migratory morphologies with longer but fewer TNTs, whereas intersecting fiber networks can support broader cell spreading and more complex intercellular connectivity [43]. These observations indicate that TNT formation and geometry are sensitive to physical properties of the surrounding matrix, including topology and available adhesive tracks. In vivo observations further support the idea that TNT-related structures are not merely artifacts of conventional cell culture. In the mouse retina, pericyte-associated interpericyte TNTs have been reported to link distinct capillary segments and participate in neurovascular coupling [36]. In developmental models such as zebrafish embryos, TNT-like connections have also been observed in vivo and shown to support intercellular transfer [42]. Together, evidence from 3D and in vivo contexts suggests that TNT-related communication is shaped by ECM architecture, tissue organization, and local biochemical cues. At the same time, these findings reinforce the need for careful structural validation, because tissue-embedded protrusions, retraction fibers, cytonemes, and other intercellular bridges may resemble TNTs unless their three-dimensional geometry and transfer route are resolved directly. Regulatory mechanisms and signaling programs underlying TNT formation Upstream signals As specialized architectures for intercellular communication, TNTs are responsive to both extracellular cues and intracellular stress states. Although the upstream triggers vary across cell types and disease models, many signals appear to converge on three interrelated cellular modules: membrane remodeling, cytoskeletal reorganization, and mobilization of trafficking machinery. Below, we summarize signaling contexts that have been linked to altered TNT abundance, TNT formation, or TNT-supportive phenotypes in different experimental systems, while emphasizing that these associations are often context-dependent and require functional validation. Growth factor and receptor signaling Growth factors and microenvironmental receptor signals frequently accompany conditions in which TNTs are reported, particularly in tumor-associated settings. Several studies suggest that epidermal growth factor (EGF)-dependent signaling and mitogen-activated protein kinase (MAPK) pathway activation can promote TNT or TNT-like structure formation in tumor-associated models [43, 44]. Beyond EGF, other growth factors can also induce TNT-like structures in specific cell types. For example, in A549 lung adenocarcinoma cells, hepatocyte growth factor (HGF) increases the number of TNT-like connections and promotes their elongation in a time- and dose-dependent manner. Available evidence further suggests that this effect is regulated through c-Met receptor tyrosine kinase and β1 integrin-mediated signaling [45]. Conceptually, these cues may act through receptor-mediated signaling cascades to shift membrane dynamics and cytoskeletal states toward protrusion formation and stabilization, thereby biasing cells toward TNT-supportive phenotypes. Oxidative stress and reactive oxygen species Oxidative stress has emerged as a recurrent context in which TNT or TNT-like structures are induced, with ROS acting as metabolic and signaling cues that can influence membrane and cytoskeletal remodeling [46–48]. In astrocyte models, hydrogen peroxide was shown to alter membrane and cytoskeletal properties and increase intercellular connections, while subsequent work linked TNT development in astrocytes to p53 activation [46, 47]. In macrophages, Rho-family guanosine triphosphatases (Rho GTPases) and actin polymerization have been implicated in TNT biogenesis, further supporting the importance of cytoskeletal remodeling in stress-associated TNT formation [49]. Mechanistically, oxidative stress may intersect with pathways involving p53, p38 MAPK, Rac1, CDC42, and other actin-regulatory modules, but the relative contribution of each pathway appears to be cell-type- and context-dependent [46–49]. Therefore, ROS-associated TNT induction should be interpreted as a stress-linked adaptive program rather than a universal mechanism; in disease settings, the same program may be co-opted to support pathological intercellular communication. Mitochondrial dysfunction and damage-associated signaling Mitochondrial dysfunction is closely linked to TNT biology, but its role is better established as a driver of mitochondrial exchange than as a fully defined upstream pathway for TNT biogenesis. In stressed or injured cells, TNT-mediated mitochondrial transfer has been reported to provide functional rescue. For example, transfer of healthy mitochondria via TNTs rescued apoptotic PC12 cells, mitochondrial Rho GTPase 1 (Miro1)-dependent mitochondrial trafficking enhanced the rescue efficacy of mesenchymal stem cells, and TNT-mediated mitochondrial transfer from mesenchymal stem cells to macrophages enhanced phagocytic function in acute respiratory distress syndrome-related models [7, 50, 51]. In oxidative injury models, mesenchymal stem cell-derived mitochondrial transfer has also been shown to protect corneal epithelial cells from mitochondrial damage, further supporting the link between mitochondrial stress and contact-dependent mitochondrial exchange [52]. These findings suggest that mitochondrial stress can increase the demand for contact-dependent mitochondrial exchange and may favor TNT-supportive phenotypes in specific injury contexts. Mitochondrial injury can also release mitochondrial-derived molecules, including mitochondrial DNA (mtDNA) and formyl peptides, which act as mitochondrial damage-associated molecular patterns (mtDAMPs). These mtDAMPs can be sensed by pattern-recognition pathways, including Toll-like receptor 9 (TLR9) and formyl peptide receptor 1 (FPR1), thereby amplifying inflammatory responses [53, 54]. Such inflammatory and metabolic stress states may create a permissive environment for TNT-associated intercellular communication. However, direct evidence that mtDAMPs themselves induce TNT formation remains limited. Therefore, mitochondrial dysfunction should be interpreted as a stress context that may favor TNT-mediated mitochondrial exchange, rather than as a universal mtDAMP-driven mechanism of TNT biogenesis. Canonical formation modes Current models commonly describe two broad routes to TNT formation: protrusion extension and cell separation. In the protrusion extension mode, actin polymerization drives de novo outgrowth of a slender protrusion that explores the environment and establishes contact with a distant target cell. In some systems, both cells may extend protrusions that meet in the intercellular space, generating a double-protrusion intermediate before a stable intercellular connection is formed [13, 55]. The transition from contact to a functional TNT likely requires local membrane remodeling and stabilization rather than simple protrusion apposition. Molecular components such as leukocyte-specific transcript 1 (LST1), M-Sec, also known as tumor necrosis factor-α-induced protein 2 (TNFAIP2), Ras-like GTPase RalA, exocyst-associated proteins, myosin, and myoferlin have been implicated in assembling TNT-supportive membrane–cytoskeletal machinery, although the identity and generality of this machinery remain context-dependent [56]. After docking, the connection may mature into different terminal architectures, including open-ended membranous continuity or more specialized junction-coupled endpoints, depending on the cellular context [15, 36]. In the cell separation mode, two cells initially in close contact migrate apart while maintaining membrane continuity at the contact site. Instead of rupturing, the shared membrane region is mechanically drawn into a thin tether, leaving a nanotubular connection between the separating cells. This route has been observed in hematopoietic progenitor cells, where TNTs were reported to emerge from the uropod of migrating cells and where cell dislodgement was proposed as a major mechanism of TNT biogenesis [57]. Immune cell studies have also provided early evidence that nanotubular connections can support long-range functional communication between cells [58]. These two modes are not mutually exclusive and may coexist within the same microenvironment. In tissue settings, TNT-related structures may combine protrusive growth, contact-dependent stretching, and local remodeling, making live-cell imaging essential for reconstructing their formation history. For example, pericyte-associated interpericyte TNTs in the retina and related neurovascular disease models illustrate that tissue-embedded TNT-like structures can be shaped by local cellular contacts, vascular geometry, and physiological or pathological microenvironmental cues [36, 59]. Dissecting the molecular determinants that bias a system toward one route versus the other is essential for interpreting TNT heterogeneity and for mapping formation mode to disease-relevant function (Fig. 2). Two major models of TNTs formation and the associated structural and functional features Cytoskeletal assembly Cytoskeletal assembly is a core determinant of TNT biogenesis and is commonly centered on linear F-actin polymerization. A key module involves Eps8 and IRSp53, which together support the formation of long, actin-rich protrusions. Through its inverse Bin–Amphiphysin–Rvs (I-BAR) domain, IRSp53 can sense and induce membrane curvature, while Eps8 and associated actin-regulatory factors help sustain linear actin elongation at the protrusion tip. This Eps8/IRSp53-dependent program has been shown to drive TNT formation in neuronal-like cells [13]. Actin-bundling and motor-associated factors further shape TNT assembly. Myosin X acts upstream of leukocyte plastin (L-plastin) in stress-induced TNT formation, suggesting that motor-linked actin organization can influence the emergence of TNT-supportive protrusions [60]. In addition, molecular modules involving LST1, M-Sec/TNFAIP2, RalA, exocyst-associated proteins, myosin, and myoferlin have been implicated in assembling membrane–cytoskeletal machinery that supports TNT formation [56]. These findings indicate that TNT biogenesis depends not only on actin polymerization itself but also on coordinated membrane remodeling, actin bundling, and vesicle trafficking machinery. The balance between linear and branched actin assembly is another important regulatory layer. The actin-related protein 2/3 (Arp2/3) complex promotes branched actin nucleation and can compete with linear actin elongation programs for actin monomers and shared regulatory factors. In several experimental systems, suppression of Arp2/3-dependent branching or shifts toward Eps8/IRSp53-dependent linear actin polymerization have been associated with increased TNT formation [13, 20]. More broadly, competition and collaboration between distinct actin assembly pathways provide a useful framework for understanding how cells allocate cytoskeletal capacity between dense branched protrusive networks and sparse long-range nanotubular connections [61]. Beyond actin, microtubule dynamics contribute to the formation and maintenance of thicker TNTs in selected systems. In macrophage membrane nanotubes, thicker structures containing both F-actin and microtubules supported long-distance vesicular traffic [14]. More recently, chaperonin-containing TCP1 subunit 4 (CCT4) has been implicated in promoting microtubule dynamics and facilitating the assembly of microtubule-containing thick TNTs [62]. Collectively, cytoskeletal assembly programs provide the physical and regulatory basis for TNT formation, while also constraining the range of cargo that can be transported through different TNT architectures. Membrane platforms and coupling to transport machinery Efficient TNT growth and function require coordinated membrane remodeling, membrane supply, and targeted trafficking. Rather than acting as a purely actin-driven protrusion event, TNT biogenesis often involves membrane–cytoskeletal platforms that couple protrusion extension to vesicle trafficking and motor-associated transport. M-Sec/TNFAIP2 is one of the best-characterized components of this machinery. M-Sec promotes membrane nanotube formation through interaction with RalA and the exocyst complex [63]. Domain-level studies further suggest that distinct regions of M-Sec contribute to plasma membrane localization, membrane deformation, and cooperation with RalA/exocyst-dependent machinery during TNT formation [64]. These findings support a model in which local membrane recruitment and targeted exocytic machinery help provide membrane material and spatial organization for TNT outgrowth. LST1 has also been implicated as a membrane-associated scaffold in TNT formation. LST1 was reported to promote assembly of a TNT-supportive molecular machinery involving M-Sec/TNFAIP2, RalA, exocyst-associated proteins, myosin, and myoferlin [56]. In cancer-related models, Ral GEF with PH domain and SH3-binding motif 2 (RalGPS2) has further been linked to TNT formation and to complexes involving protein kinase B (Akt), 3-phosphoinositide-dependent protein kinase 1 (PDK1), LST1, and RalA, suggesting that upstream scaffold and signaling adaptors may tune membrane-platform assembly in a context-dependent manner [65]. Vesicle trafficking regulators provide an additional layer of coupling between TNT formation and functional transfer. In neural cell systems, Rab8a and Rab11a were reported to regulate TNT-mediated intercellular communication, with knockdown reducing functional TNT formation and vesicle transfer [66]. These observations suggest that TNT-associated communication depends not only on protrusion formation but also on the trafficking machinery that supplies membrane components and supports cargo movement. Motor proteins further connect membrane platforms with cytoskeletal transport. In this context, myosin X has been shown to be essential for HIV-1 Nef-induced TNT formation and intercellular Nef transfer between macrophages and T cells [37]. More recently, myosin X was also reported to act upstream of L-plastin in stress-induced TNT formation [60]. These factors point to a coordinated model of TNT biogenesis, in which membrane supply, scaffolding, trafficking regulators, and motor-associated transport are integrated with actin-driven protrusion to support elongation, stability, and functional cargo transfer. Diversity of TNT-mediated cargo transfer Organelle transfer Lysosome transfer Early work established that TNTs can function as physical conduits for intercellular organelle exchange, enabling the direct transfer of lysosome-related and other membranous compartments, including early and late endosome-related organelles [67]. This mode of transport depends on sustained membrane continuity and cytoskeletal support and is mechanistically distinct from EV release and uptake or bulk membrane fusion events [67]. In neurodegeneration-related models, lysosome-associated transfer through TNTs is frequently discussed in the context of pathogenic protein exploitation. Fibrillar α-synuclein has been shown to spread from donor to recipient cells through TNT-mediated trafficking of lysosome-like vesicles, indicating that degradative compartments can be co-opted as carriers for pathological cargo [68]. Subsequent work further showed that α-synuclein fibrils can alter lysosomal morphology and function, promote transfer of damaged lysosomes through TNTs, and facilitate seeding of soluble α-synuclein after delivery [69]. Such vesicular confinement may help protect pathogenic assemblies from extracellular degradation and facilitate their delivery into recipient cells, where they can promote aggregation of endogenous soluble α-synuclein [68, 69]. By contrast, lysosomal or autophagosomal transfer may also have compensatory roles in selected disease models. In cystinosis models, hematopoietic stem cell-derived macrophages have been shown to form TNTs and deliver cystinosin-bearing lysosomes to cystinosin-deficient cells, providing a mechanism of lysosomal cross-correction [70]. In squamous cell carcinoma models, TNTs have been implicated in autophagosome transfer and long-distance cell-to-cell communication, with focal adhesion kinase (FAK) identified as a regulator of TNT assembly through a matrix metalloproteinase-2 (MMP-2)-dependent mechanism [71]. In podocyte models of diabetic nephropathy, the M-Sec/TNFAIP2 system was reported to protect autophagy by supporting the exchange of autophagosomes and lysosomes, thereby ameliorating advanced glycation end product-induced lysosomal dysfunction and apoptosis [72]. These findings suggest that TNT-mediated lysosomal or autophagosomal exchange may contribute to stress adaptation, lysosomal cross-correction, or degradative support in specific disease contexts, although whether this represents a general mechanism of functional complementation across other cell types or stress conditions remains to be established. TNT-mediated transfer of lysosome-related compartments therefore illustrates a functionally ambivalent form of organelle sharing. In some settings, this route may facilitate the spread of pathogenic aggregates; in others, it may support lysosomal cross-correction, degradative recovery, or stress adaptation. Lysosome-related organelle exchange thus provides a mechanistic perspective for understanding how cells redistribute degradative capacity under tissue stress and disease-associated microenvironmental pressure. Mitochondrial transfer Compared with lysosome-related compartments, mitochondrial transfer more directly affects the bioenergetic state and stress tolerance of recipient cells. TNT-mediated mitochondrial exchange has been reported in several experimental systems and is most strongly supported in models where live imaging, mitochondrial labeling, and functional rescue assays were combined. In apoptotic PC12 cells, transfer of functional mitochondria through TNTs rescued injured recipient cells, providing early evidence that TNT-mediated mitochondrial transfer can support cellular recovery [7]. In mesenchymal stem cell-based repair models, Miro1-dependent mitochondrial trafficking enhanced rescue efficacy, while mitochondrial transfer from mesenchymal stem cells to macrophages through TNTs improved macrophage phagocytic function in acute respiratory distress syndrome-related models [50, 51]. In oxidative injury models, mesenchymal stem cell-derived mitochondrial transfer has also been shown to protect corneal epithelial cells from mitochondrial damage [52]. Mechanistically, mitochondrial transfer through TNTs depends on both cytoskeletal architecture and motor-associated trafficking. Actin-rich TNTs may support short-range organelle movement, whereas thicker or composite TNTs containing microtubules are more compatible with long-distance transport of larger organelles [14, 38]. In B-lymphoma cell systems, bidirectional mitochondrial movement through TNTs was linked to cooperation between microtubule-associated kinesin and actin-associated myosin VI [38]. These findings support the view that mitochondrial transfer is not a passive redistribution event, but a regulated process shaped by TNT structure, donor–recipient state, and cargo-transport machinery. In tissue damage and repair contexts, TNT-mediated mitochondrial transfer is commonly interpreted as a form of metabolic rescue. Distressed cells may generate stress-associated cues that favor TNT formation or mitochondrial donation, although the specific signals and directionality vary by model. Therefore, mitochondrial transfer should be described as a context-dependent rescue mechanism rather than a universal response to injury. In cobalt nanoparticle-induced neurotoxicity models, astrocyte-derived mitochondria have been reported to transfer to neurons through TNTs and protect against mitochondrial damage [73]. These observations support the concept that intercellular mitochondrial exchange can help buffer bioenergetic stress in selected injury contexts. Mitochondrial transfer can also be exploited in cancer. In bladder cancer models, TNT-mediated mitochondrial transfer between heterogeneous cancer cell populations increased recipient-cell invasiveness [74]. In glioblastoma models, TNT-mediated mitochondrial transfer from tumor cells to non-tumor astrocytes promoted adaptation to hypoxic and metabolic stress in the tumor microenvironment [75]. In addition, endothelial-to-cancer cell mitochondrial transfer through TNTs has been reported to modulate chemoresistance [76]. These findings indicate that mitochondrial transfer can support metabolic plasticity, invasion, and stress tolerance in selected tumor contexts. Mitochondrial transfer through TNTs therefore represents one of the clearest examples of context-dependent organelle exchange. In injury and repair settings, it may provide bioenergetic support to compromised cells; in cancer, similar transfer routes may promote adaptation, invasion, and treatment resistance. Future studies should distinguish TNT-mediated mitochondrial transfer from transfer through EVs, cell fusion, or phagocytic uptake, and should combine route-resolved imaging with functional assays of mitochondrial activity in recipient cells. Transfer of other organelles and endomembrane components Beyond lysosomes and mitochondria, TNTs have also been reported to support the movement of additional endomembrane-associated components. In astrocyte and neuron models, TNT development was induced by stress conditions such as hydrogen peroxide exposure or serum depletion, and live-cell imaging detected transfer of endoplasmic reticulum-, Golgi-, endosome-, and amyloid β-associated signals through TNTs [47]. Early work in normal rat kidney cells also showed constitutive, actomyosin-dependent exchange of endocytic organelles through TNT-like structures, further supporting the capacity of TNT-related connections to mediate transfer of endomembrane-associated compartments [67]. These findings suggest that TNTs may function as broader conduits for selected endomembrane components rather than being restricted to single-organelle transfer. However, the evidence for transfer of non-mitochondrial and non-lysosomal organelles remains less extensive than that for mitochondrial or lysosome-related exchange. Fluorescent signals attributed to endoplasmic reticulum, Golgi, or endosomal material may represent movement of organelle fragments, vesicular carriers, or membrane-associated cargo, and should therefore be interpreted with route-resolved imaging and appropriate controls. Future studies should distinguish true organelle transfer from vesicle trafficking, membrane tethering, EV uptake, or local signal diffusion, and should determine whether transferred endomembrane components retain functional activity in recipient cells. RNA transfer Studies in mammalian co-culture, tumor–stromal, and viral infection models suggest that TNTs or TNT-like structures can mediate intercellular transfer of RNA species, including messenger RNAs (mRNAs) and long non-coding RNAs (lncRNAs) [77, 78], microRNAs (miRNAs) [79], and viral RNA genomes [80]. Compared with soluble signaling or EV-mediated RNA delivery, TNT-associated RNA transfer is contact-dependent and may allow donor cells to deliver informational cargo directly to recipient cells, with potential consequences for transcriptome regulation, recipient-cell phenotype, and disease progression [77–80]. Early studies using mammalian co-culture systems showed that full-length mRNAs can move between cells through membrane nanotube-like extensions rather than solely through EV-mediated routes [77]. More recently, transcriptome-wide analysis in a human-to-mouse co-culture model demonstrated contact-dependent intercellular transfer of mRNAs and lncRNAs, supporting the idea that TNT-mediated RNA exchange may involve a broader set of transferred transcripts rather than isolated RNA species [78]. These findings suggest that TNTs can transmit RNA-encoded information capable of influencing recipient-cell regulatory states, although the functional consequences of transferred transcripts remain transcript- and context-dependent. TNT-associated transfer has also been described for small regulatory RNAs. In tumor–stromal co-culture models, oncogenic miRNAs were reported to transfer directly between cells through TNTs, supporting a mechanism by which cancer cells may reprogram stromal or endothelial phenotypes in the tumor microenvironment [79]. However, miRNA transfer through TNTs should be interpreted cautiously, because small RNAs can also be transported by EVs, RNA-binding protein complexes, or other extracellular carriers. Strong attribution therefore requires route-resolved imaging, EV controls, and evidence that transferred RNA remains functional in recipient cells. In viral infection models, RNA genomes may also exploit TNT-associated routes. In influenza virus-infected epithelial cells, TNTs were reported to facilitate transfer of viral proteins and viral genome from infected to naïve cells, with evidence of productive viral replication in recipient cells even under conditions designed to limit extracellular viral spread [80]. These observations suggest that TNT-mediated RNA or viral genome transfer may contribute to cell-to-cell viral dissemination and immune evasion. Nevertheless, whether RNA transfer through TNTs results in productive replication, stable gene-expression changes, or transient signaling effects depends on the type of RNA, the recipient-cell state, and host antiviral or RNA-surveillance mechanisms. RNA transfer expands the functional repertoire of TNTs from organelle sharing to horizontal information exchange. Future studies should distinguish RNA movement through TNTs from EV-mediated RNA delivery, membrane-associated carryover, and cell fusion, and should combine single-molecule RNA imaging, donor–recipient tracing, and functional assays to determine whether transferred RNA reshapes recipient-cell behavior. Protein transfer In addition to organelles and RNAs, TNTs have been implicated in the intercellular transfer of proteins, protein-containing vesicles, and protein assemblies [81–85]. Compared with soluble protein secretion or EV-mediated delivery, TNT-associated protein transfer is contact-dependent and can occur along defined intercellular connections. However, this category should be interpreted carefully, because protein signals detected in recipient cells may represent direct protein movement, vesicle-associated transfer, organelle-associated transfer, or membrane carryover. Therefore, stronger attribution requires visualization of protein movement along TNTs together with controls excluding EV uptake, cell fusion, and phagocytic engulfment. In immune systems, TNT-like connections have been linked to the exchange of immune-relevant protein cargo. Major histocompatibility complex (MHC) class I molecules were shown to transfer between cells through TNTs, supporting a role for TNTs in the redistribution of surface immune molecules [81]. In dendritic cells (DCs), CD40 ligand (CD40L)-induced TNT-like networks were reported to facilitate intercellular trafficking of endosome-associated vesicles and antigen-associated material, suggesting that TNT-related connections may contribute to local immune coordination under type 1 inflammatory conditions [82]. These findings support a role for TNTs in immune-cell communication, although the extent to which this mechanism contributes to antigen presentation or immune surveillance in vivo remains to be defined. In neurodegeneration and protein-misfolding contexts, TNTs may provide a route for the spread of pathogenic protein assemblies. Prion proteins have been reported to hijack TNTs for intercellular spread, providing early evidence that infectious proteinaceous cargo can exploit these structures [83]. Pathological Tau assemblies were also shown to transfer between neurons through TNTs, supporting the possibility that TNT-mediated transfer may contribute to propagation of proteotoxic stress in neurodegenerative disease models [84]. These observations align with broader models of prion-like dissemination, but they also highlight the need to distinguish TNT-mediated transfer from EV-associated spread, synaptic transfer, and other contact-dependent routes. In cancer, TNT-associated protein transfer has been linked to microenvironmental support and therapy resistance. In chronic myeloid leukemia models, stromal TNTs were reported to mediate vesicle and protein transfer to leukemic cells, and this transfer contributed to stroma-provided imatinib resistance [85]. This finding suggests that TNT-mediated protein-associated cargo exchange can participate in adaptive tumor–stroma communication. Nevertheless, cancer-related protein transfer should not be generalized without direct cargo-level evidence, because many TNT studies in tumors demonstrate transfer of mixed cellular contents rather than specific protein cargos. TNT-mediated protein transfer appears to involve several distinct cargo formats, including surface proteins, antigen-associated material, pathogenic protein assemblies, and vesicle-associated protein cargo. Future studies should identify the specific transferred proteins, define whether transfer occurs as soluble protein, membrane-associated protein, or vesicle-associated cargo, and determine whether the transferred protein remains functional in recipient cells. Calcium transfer Beyond macromolecules and organelles, TNTs and TNT-like connections have been implicated in intercellular calcium ion (Ca2⁺) signaling. Early immune-cell studies showed functional connectivity between distant cells connected by tunneling nanotubules, including propagation of Ca2⁺ signals between dendritic cells and THP-1-derived monocytic cells [58]. In developing neuron–astrocyte co-cultures, transient nanotubes were also reported to facilitate electrical coupling and Ca2⁺ signaling between distant cells [41]. These findings suggest that TNT-related connections can support rapid signal transmission in selected cellular contexts. However, the mechanism of TNT-associated Ca2⁺ signaling should not be interpreted uniformly. In SH-SY5Y neuroblastoma and HEK293 cell systems, functional inositol 1,4,5-trisphosphate receptors (IP3Rs) were detected along tunneling membrane nanotubes, and IP3R-dependent Ca2⁺-induced Ca2⁺ release was proposed to support active propagation of Ca2⁺ signals within these structures [86]. In contrast, later work using engineered membrane nanotube-forming cells showed that long-range Ca2⁺ signal communication through nanotubes required Cx43-dependent gap junction coupling and was mediated primarily by diffusion of inositol 1,4,5-trisphosphate (IP3), rather than by direct diffusion of Ca2⁺ itself [87]. Thus, Ca2⁺ may serve as the observable signal, whereas IP3 diffusion and junctional coupling can be the underlying transmission mechanism in some systems. Additional epithelial and tissue-based models support the idea that Ca2⁺ signaling through TNT-related structures depends strongly on terminal architecture. In human retinal pigment epithelial cells, TNTs were reported to support multiple levels of intercellular communication, including Ca2⁺ signal propagation [32]. In the retina, pericyte-associated interpericyte TNTs were shown to participate in neurovascular coupling and to communicate with neighboring pericyte processes through Cx43-mediated gap junctions [36]. Together, these studies indicate that TNT-associated Ca2⁺ signaling may occur through several related mechanisms, including open cytoplasmic continuity, IP3R-dependent amplification along nanotubes, and gap junction-coupled IP3 transmission at TNT termini. Ca2⁺ signaling through TNTs is best viewed as a route-dependent and architecture-dependent process rather than a single universal transfer mechanism. Future studies should combine live Ca2⁺ imaging, connexin/gap junction perturbation, IP3 pathway manipulation, 3D structural validation, and controls for paracrine adenosine triphosphate (ATP) signaling to determine whether observed Ca2⁺ waves reflect direct TNT-mediated transfer, junction-coupled signaling, or secondary extracellular signaling. TNTs in disease contexts As a highly dynamic form of intercellular communication, TNTs may contribute to tissue homeostasis but can also exhibit a double-edged behavior in pathological microenvironments. Elucidating how TNTs are regulated across disease contexts is important for understanding how cell networks coordinate in vivo and for evaluating translational opportunities. Below we summarize key disease-associated roles of TNTs across four major areas (Fig. 3). Roles of TNTs across four major disease microenvironments Neurodegenerative diseases In the nervous system, TNTs and TNT-like structures have been reported in neuron–neuron, neuron–glia, and microglia–neuron communication [41, 84, 88–90]. Their roles appear highly context-dependent: the same route of intercellular transfer may contribute to pathogenic protein spread, but may also support compensatory organelle exchange and cellular rescue under stress. On the detrimental side, TNTs can provide contact-dependent routes for the dissemination of pathogenic protein assemblies. Prion proteins were shown to hijack TNTs for intercellular spread, providing early evidence that infectious proteinaceous cargo can exploit TNT-mediated communication [83]. Pathological Tau assemblies were also reported to transfer between neurons through TNTs, supporting a potential role for TNTs in the propagation of proteotoxic stress in Alzheimer’s disease-related models [84]. In α-synuclein models, fibrillar α-synuclein can spread through TNT-mediated trafficking of lysosome-like vesicles, and subsequent work further showed that α-synuclein fibrils can disrupt lysosomal morphology and function while promoting protein misfolding propagation through TNTs [68, 69]. More recently, TNTs between neuronal and microglial cells were shown to allow bidirectional transfer of α-synuclein and mitochondria, indicating that glial–neuronal TNT networks may participate in both aggregate handling and organelle exchange [88]. On the protective side, TNT-mediated transfer may also serve as a rescue mechanism in selected neurodegeneration-related models. Microglia have been reported to establish TNTs with neurons and rescue neurons from aggregate-induced dysfunction and death, in part through the exchange of organelles, vesicles, proteins, and healthy mitochondria [89]. In peripheral neuropathy models, mitochondrial transfer from glia to neurons through TNT-like structures was also shown to protect against neuropathic injury, supporting the idea that glia-derived mitochondrial support can preserve neuronal function under stress [90]. These findings suggest that TNTs should not be viewed solely as conduits for pathogenic spread; in some contexts, they may also enable protective metabolic or organelle-based support. This duality has important therapeutic implications. In neurodegenerative and nervous-system injury contexts, TNTs may facilitate intercellular propagation of misfolded proteins, yet they may also support aggregate handling, mitochondrial rescue, and neuronal survival. Therapeutic strategies should therefore avoid indiscriminate TNT suppression and instead distinguish disease-promoting cargo transfer from protective glia–neuron support. Cancer In cancer, TNTs and TNT-like networks have been implicated in therapy resistance, metabolic coupling, tumor–stroma communication, and immune modulation [10, 74, 79, 85, 91]. Their effects are context-dependent and often reflect the type of cargo being transferred, including drug-associated material [10], mitochondria [74, 91], regulatory RNAs [79], and vesicle- or protein-associated cargo [85]. Therefore, cancer-associated TNTs should be interpreted as adaptive communication routes whose functional consequences depend on tumor type, microenvironmental context, treatment pressure, and transferred cargo. Therapy resistance is one of the most frequently discussed cancer-related functions of TNTs. In pancreatic cancer models, chemotherapeutic stress induced TNT formation, and TNTs were reported to mediate intercellular drug efflux, thereby redistributing cytotoxic burden between connected cells [10]. In breast cancer cells, 5-fluorouracil treatment promoted TNT formation and enhanced cell survival, further supporting the link between treatment stress and TNT-dependent adaptive responses [92]. In hematologic malignancies, B-cell precursor acute lymphoblastic leukemia cells were shown to use TNTs to communicate with bone marrow stromal cells and orchestrate a protective microenvironment [93]. Similarly, in chronic myeloid leukemia models, stromal TNTs mediated vesicle and protein transfer to leukemic cells and contributed to stroma-provided imatinib resistance [85]. In acute myeloid leukemia-related models, cytarabine treatment and nuclear factor kappa B (NF-κB) inhibition reduced TNT formation, suggesting that stress-responsive inflammatory signaling may influence TNT abundance in selected leukemia contexts [94]. Metabolic coupling is another prominent theme. In bladder cancer models, TNT-mediated mitochondrial transfer between heterogeneous cancer cell populations increased recipient-cell invasiveness [74]. In glioblastoma models, TNT-mediated mitochondrial transfer from tumor cells to non-tumor astrocytes promoted adaptation to hypoxic and metabolic stress [75], while astrocyte-to-glioblastoma mitochondrial transfer through GAP43-positive contact-dependent structures enhanced glioblastoma tumorigenicity [95]. Endothelial-to-cancer cell mitochondrial transfer through TNTs has also been reported to modulate chemoresistance [76]. Together, these findings indicate that TNT-related mitochondrial exchange can support metabolic plasticity, stress tolerance, and therapy resistance in selected tumor contexts. TNTs may also remodel the immune and stromal compartments of the tumor microenvironment. Tumor–stromal co-culture studies showed direct transfer of oncogenic microRNAs through TNTs, suggesting a route by which cancer cells may alter stromal or endothelial phenotypes [79]. In cancer–immune cell systems, intercellular nanotubes were shown to mediate mitochondrial trafficking between cancer cells and immune cells, altering immune-cell metabolism and function [91]. More recently, mitochondrial transfer in the tumor microenvironment was reported as a mechanism of immune evasion, further supporting the idea that organelle exchange can reshape antitumor immunity [96]. In intrahepatic cholangiocarcinoma models, TNT-mediated transfer of tumor-derived arachidonic acid to tumor-associated macrophages was reported to reprogram macrophage function and promote tumor progression [97]. These findings suggest that TNT-associated transfer can influence not only tumor-cell fitness but also the functional state of stromal and immune cells. Mechanistically, cancer-associated TNT formation appears to be regulated by multiple, non-universal pathways. In squamous cell carcinoma models, focal adhesion kinase (FAK) was identified as a regulator of TNT assembly through a matrix metalloproteinase-2 (MMP-2)-dependent mechanism [71]. In leukemia models, the sensitivity of TNT formation to NF-κB inhibition indicates that inflammatory or stress-responsive signaling may also contribute to TNT-supportive phenotypes [94]. However, these regulatory mechanisms should not be generalized across all tumors without direct validation, because TNT abundance, cargo type, and functional consequences vary substantially by cell type, microenvironment, and treatment condition. Cancer-associated TNTs are best interpreted as adaptive communication routes whose consequences depend on tumor type, microenvironmental pressure, treatment exposure, and transferred cargo. In many tumor settings, TNTs appear to support survival, metabolic adaptation, microenvironmental remodeling, and treatment tolerance. Translational strategies should therefore focus on selectively disrupting disease-promoting TNT-mediated transfer, while preserving or avoiding interference with potentially protective intercellular communication in normal tissues. Cardiovascular diseases In the cardiovascular system, TNTs and TNT-like structures have been implicated in cardiac morphogenesis, vascular cell communication, ischemic stress responses, and reparative mitochondrial transfer [98–101]. Compared with cancer or neurodegeneration, cardiovascular TNT research remains relatively early, and many observations are based on TNT-like structures or in vitro models. Therefore, cardiovascular TNT biology should be interpreted with particular attention to structural validation, cell type, and disease context. During cardiac development, TNT-like structures have recently been shown to connect cardiomyocytes in the myocardium with endocardial cells. These structures transported cytoplasmic proteins, transduced signals between the two cardiac layers, and contributed to ventricular trabeculation and patterning during heart formation [98]. This study provides direct evidence that TNT-like structures can participate in long-distance cell–cell communication during mammalian cardiac morphogenesis. In vascular contexts, TNT-related communication has been described between pericytes and endothelial cells. In normal and tumoral angiogenesis, pericyte/endothelial TNTs were reported to support intercellular communication, suggesting a possible role in coordinating vascular remodeling [99]. More recently, pericyte-to-endothelial TNT communication was shown to influence endothelial metabolism, and disruption of this communication by a docosahexaenoic acid-derived diol altered pericyte–endothelial cell interactions [102]. These findings suggest that TNT-like structures may contribute to vascular cell coupling, although their direct role in vascular tone regulation or nitric oxide production should not be inferred without TNT-specific evidence. In pathological cardiac stress, TNT-mediated communication may be altered by ischemic injury. In cardiac cell models and neonatal primary cardiomyocyte cultures, ischemia increased TNT formation, while antioxidant treatment reduced ischemia-induced TNT formation, supporting a role for oxidative stress in regulating TNT-mediated communication between cardiac cells [100]. These findings suggest that TNTs may participate in cardiac stress responses, but whether they amplify injury or support adaptive rescue likely depends on timing, cell type, and cargo. TNT-associated mitochondrial transfer has also been studied as a reparative mechanism in cardiovascular injury models. Mesenchymal stem cells were reported to rescue cardiomyoblasts from cell death in an in vitro ischemia model through direct cell–cell connections [103]. In anthracycline-induced cardiomyopathy models, induced pluripotent stem cell-derived mesenchymal stem cells with high intrinsic Miro1 and sensitivity to tumor necrosis factor-α promoted mitochondrial transfer and protected cardiomyocytes from injury [104]. Bone marrow-derived mesenchymal stem cells have also been shown to rescue injured H9c2 cardiomyoblasts through transfer of intact mitochondria via TNTs [101]. In vascular repair models, mesenchymal stem cell-mediated mitochondrial transfer to endothelial cells promoted metabolic reprogramming and vascular regeneration in acute respiratory distress syndrome-related injury [105]. Together, these findings support the concept that TNT-mediated mitochondrial transfer may contribute to metabolic rescue in selected cardiac and vascular injury contexts. The cardiovascular literature points to a highly context-dependent view of TNT biology. TNT-like structures may support cardiac morphogenesis and vascular cell coordination, while ischemia-induced TNT formation may reflect either adaptive stress communication or potential injury amplification. Reparative mitochondrial transfer represents a promising direction, but future studies should distinguish TNT-mediated transfer from EV-mediated mitochondrial delivery, cell fusion, and paracrine effects, and should validate the functional relevance of TNTs in vivo across specific cardiovascular disease models. Pathogen dissemination As F-actin-rich intercellular connections, TNTs and TNT-like structures can be exploited by pathogens, particularly viruses, as routes for direct cell-to-cell dissemination. Compared with extracellular release and diffusion, TNT-associated spread may reduce exposure to neutralizing antibodies, extracellular antiviral factors, or immune surveillance, although the extent of this advantage varies by pathogen and experimental system [80, 106–111]. Therefore, pathogen-associated TNT transfer should be interpreted as one component of cell-to-cell spread, alongside virological synapses, filopodia-like extensions, extracellular vesicles, and cell fusion. In HIV-1 infection, TNT-related mechanisms have been described mainly in myeloid and immune-cell contexts. HIV infection of macrophages was shown to increase TNT formation, and HIV particles were observed within these structures, supporting a potential route for intercellular HIV trafficking [106]. M-Sec was later reported to facilitate HIV-1 cell-to-cell transmission through multiple mechanisms, including enhanced TNT formation and increased cell motility [107]. In addition, myosin X was shown to be essential for HIV-1 Nef-induced TNT formation and intercellular Nef transfer between macrophages and T cells [37]. These findings indicate that HIV-1 may exploit TNT-associated routes, although TNT-mediated transfer should be distinguished from other contact-dependent mechanisms such as cell fusion or virological synapse-like communication. Respiratory viruses provide additional examples of TNT-associated or TNT-like spread. Influenza A virus was reported to exploit tunneling nanotubes for cell-to-cell spread, including transfer of viral proteins and viral genome-associated material to naïve epithelial cells, with evidence of productive infection even when extracellular viral spread was limited [80]. Human metapneumovirus (HMPV) infection was shown to induce actin-dependent intercellular extensions and branched cell-associated networks in human bronchial epithelial cells, consistent with direct cell-to-cell spread through TNT-like structures [108]. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), helium-ion microscopy of infected Vero E6 cells revealed long tunneling nanotubes connecting infected cells, together with syncytia and abundant extracellular vesicles [109]. Because these structures coexist, SARS-CoV-2-related TNT observations should be interpreted with caution and require route-resolved evidence to distinguish TNT-mediated transfer from fusion- or vesicle-associated spread. Other viral systems further support the diversity of pathogen–TNT interactions. In placental trophoblasts, Zika virus (ZIKV) non-structural protein 1 (NS1) was reported to drive TNT formation, enabling transfer of viral particles, proteins, mitochondria, and RNA to neighboring cells while dampening interferon responses [110]. In Newcastle disease virus (NDV) models, mutation of the methyltransferase K-D-K-E motif influenced intercellular viral transmission, providing evidence that viral enzymatic determinants can affect TNT-associated or cell-to-cell dissemination routes [111]. For pathogen dissemination, the key point is that TNTs may provide protected intercellular routes for viral components, genomes, organelles, and signaling molecules. However, pathogen dissemination studies should avoid assigning all cell-to-cell spread to TNTs without direct structural and functional validation. Future work should combine live-cell imaging, viral genome and protein tracking, genetic disruption of TNT-regulatory machinery, and controls for extracellular virions, EVs, synapses, and syncytia to define when TNTs are necessary, sufficient, or merely associated with pathogen spread. Intervention strategies targeting TNTs Pharmacological perturbation of TNT formation and function Growing interest has positioned TNTs as potential targets for experimental modulation, particularly in cancer and viral infection [112, 113]. However, pharmacological manipulation of TNTs remains exploratory, and no currently available compound can be regarded as TNT-specific. Most agents used to reduce TNT abundance or TNT-associated transfer also affect broader cellular processes, including cytoskeletal organization, proliferation, metabolic signaling, inflammation, and cell viability. Therefore, reductions in intercellular transfer after pharmacological treatment should not be attributed to TNT inhibition alone unless supported by route-resolving imaging, viability controls, assessment of general cellular morphology, and comparison with alternative transfer routes such as extracellular vesicle uptake or cell fusion. Below, we summarize representative pharmacological tools and candidate modulators reported to affect TNT formation or function, while emphasizing their limited specificity and the need for careful interpretation (Table 1). Table 1Inhibitors targeting TNTs and their mechanisms of actionDugs/InterventionsMechanism of actionResearch models/PhenomenaKey LiteratureCytochalasin DInhibit F-actin polymerization, thereby blocking TNT formationThe number of TNTs decreases in treated cells; TNT-mediated material transport is impairedZhang et al. used CytoD to interfere with TNT formation and transport, which significantly reduced their formation and transport [114]Cytochalasin BCombine with F-actin to block TNT formationThe number of TNTs significantly decreases in PC12 cells and other cell linesBukoreshtliev et al. found that CytoB (350 nM) effectively inhibits TNT formation [115]Latrunculin ABlock actin polymerization inhibits TNT formationThe number of TNTs significantly decreases in multicellular modelsSenol et al. reported that Latrunculin A also blocks TNT formation [116]Cytarabine (Ara-C)Reduce TNT formation and the number of TNTs induced by HTLV-1The number of TNTs decreases in HTLV-1 infected cells; TNT formation rate decreases in AML cellsOmsland et al. reported that TNT formation is downregulated by Ara C; they also found that Ara C reduces HTLV-1 associated TNTs [117]MetforminActivate AMPK/inhibit the mTOR pathway, indirectly suppress TNT formationThe number of TNTs decreases in cancer cell modelsVitali et al. found that the mTOR inhibitor metformin can inhibit TNTs [118]Everolimus (mTOR inhibitor)Inhibit mTOR signaling, reducing TNT formationThe number of TNTs decreases in cancer cell modelsVitali et al. reported that everolimus inhibits the formation of TNTs [118]Arp2/3 complex inhibitorInhibit branched actin nucleation, reducing TNT precursor formationThe number of filopodia and TNTs formation decreasesKeller et al. reported Arp2/3 inhibition weakened filopodia/TNT-related transport [119]NF-κB inhibitor (combined with Ara-C)Inhibit NF-κB signaling pathway, simultaneously reducing TNT formationThe number of TNTs decreases in AML modelsOmsland et al. reported that the formation of TNTs is downregulated by NF-κB inhibition [117] Inhibitors targeting TNTs and their mechanisms of action F-actin cytoskeleton-perturbing agents Because F-actin constitutes a core structural scaffold for many TNTs, actin-targeting compounds have been widely used as experimental tools to perturb TNT formation and TNT-associated transfer [47, 115]. Cytochalasin D and cytochalasin B cap filament barbed ends and inhibit further polymerization, whereas latrunculin A is commonly used to sequester G-actin monomers and prevent filament assembly. These agents have been used to reduce the abundance of actin-based TNT-like connections and to assess TNT-associated intercellular transfer in several experimental systems [47, 115, 120]. However, these compounds are not TNT-specific. They broadly disrupt actin-dependent processes, including cell shape, adhesion, migration, endocytosis, phagocytosis, vesicle trafficking, cytokinesis, and cell viability. Therefore, reduced cargo transfer after actin perturbation cannot by itself be taken as definitive evidence of TNT-specific inhibition. Stronger attribution requires complementary approaches, such as live-cell visualization of cargo movement along TNTs, quantification of TNT abundance and integrity, rescue or genetic perturbation experiments, and controls excluding reduced transfer caused by impaired donor cell health, recipient cell uptake, extracellular vesicle release, or cell fusion. Arp2/3 complex inhibitors The actin-related protein 2/3 (Arp2/3) complex regulates branched actin nucleation and thereby influences the balance between branched actin networks and linear actin-based protrusive structures. CK-666 is commonly used as an Arp2/3 inhibitor and acts by stabilizing the inactive state of the Arp2/3 complex, thereby blocking the activating conformational change required for branched actin nucleation [121]. In TNT studies, CK-666 has been used to probe how actin nucleation programs influence TNT formation and TNT-associated transfer in specific cellular systems [13, 122]. However, the effects of Arp2/3 inhibition should not be interpreted uniformly across contexts. In some models, CK-666 has been reported to promote TNT formation by shifting actin organization away from branched actin networks toward linear actin elongation [13], whereas in other systems Arp2/3 inhibition has been used to test whether Arp2/3 activity contributes to TNT formation [122]. These findings indicate that Arp2/3 dependency is likely cell-type- and context-dependent. The timing of inhibitor application is also critical. Because many mature TNTs are supported predominantly by linear F-actin bundles, Arp2/3 inhibition is more plausibly expected to affect early protrusion initiation, branching-to-linear actin remodeling, or de novo TNT formation than to act as a direct disruptor of already established TNTs. Evidence that CK-666 destabilizes pre-existing TNTs or blocks transport through mature TNTs remains less well defined. Future experiments should therefore distinguish pretreatment protocols that prevent or bias new TNT formation from acute treatment protocols applied after TNTs have already formed. Live-cell imaging, time-resolved TNT quantification, and separate assessment of TNT number, TNT persistence, and cargo flux are needed to determine whether Arp2/3 inhibition affects TNT biogenesis, maintenance, or function. Nucleoside analogs Cytarabine (Ara-C) is a nucleoside analog widely used in acute myeloid leukemia (AML) and is known to affect DNA synthesis, cell proliferation, and cell viability. In specific infection-related models, particularly human T-cell leukemia virus type 1 (HTLV-1)-expressing immune cells, Ara-C has been reported to reduce virus-induced TNT formation and limit cell-to-cell viral transmission [123]. However, this observation should be interpreted cautiously. Because Ara-C has broad cytotoxic and antiproliferative effects, reduced TNT abundance may reflect indirect effects on cellular activation state, proliferation, morphology, or survival rather than selective inhibition of TNT biogenesis. At present, the available evidence remains limited to defined viral contexts and AML-related models [94, 123], and it is unclear whether Ara-C affects TNT formation or function more broadly across other cell types or disease settings. Therefore, Ara-C should be regarded as a context-specific pharmacological observation rather than a generalizable TNT-targeting strategy, and any consideration of therapeutic repurposing would require further validation with dose–response analysis, viability controls, time-resolved TNT imaging, and comparison with alternative routes of viral or cargo transfer. Metabolic and signaling pathway modulators Metformin and Everolimus represent two clinically relevant agents frequently discussed in relation to cellular stress pathways and growth control [118, 124]. Metformin can activate AMPK and indirectly suppress mTOR signaling, and has been reported in some cancer cell models to reduce TNT formation [125]. Everolimus, an mTOR inhibitor, has likewise been reported to suppress TNT generation in multiple tumor cell systems [126]. Collectively, these findings suggest that nutrient-sensing and growth-control pathways may influence the propensity to form TNT networks, and that pathway-targeted therapies could modulate TNT-dependent communication as part of their broader cellular effects [127]. NF-κB pathway modulation Nuclear factor-κB (NF-κB) is a central transcriptional regulator of inflammation, immune activation, cell survival, and tumor biology. In AML-related models, pharmacological inhibition of NF-κB has been associated with reduced TNT formation, and Ara-C treatment was also reported to decrease TNT abundance in parallel with reduced NF-κB activity [94]. These findings suggest that inflammatory or stress-responsive transcriptional states may influence TNT-supportive phenotypes in this specific context. However, the available evidence does not establish NF-κB signaling as a universal or direct regulator of TNT biogenesis. NF-κB inhibition can broadly affect cytokine production, cellular activation, adhesion, proliferation, apoptosis, and treatment sensitivity, any of which may indirectly alter TNT abundance or apparent intercellular transfer. Therefore, reduced TNT formation after NF-κB inhibition should be interpreted cautiously and should not be taken as direct evidence that immunomodulatory interventions generally reshape TNT-mediated communication or improve therapeutic outcomes through TNT inhibition. Future studies should combine genetic perturbation of NF-κB pathway components, downstream target analysis, time-resolved TNT imaging, viability controls, and functional rescue experiments to determine whether NF-κB directly regulates TNT formation or acts indirectly through broader changes in cell state. Precision approaches based on nanotechnology or genome editing Beyond small-molecule inhibitors, precision strategies grounded in nanotechnology and genome editing offer complementary routes to modulate TNT-associated biology [128]. Nanotechnology-based platforms may be designed either to selectively disrupt TNTs or to exploit TNT routes for targeted delivery. For example, approaches that leverage stress-responsive TNT dynamics have proposed using near-infrared control of photosensitizers, such as IR780 coupled to mitochondria, to modulate TNT formation or induce TNT disruption in a programmable manner [129, 130]. In the field of gene editing, CRISPR/Cas9 technology can be used to knock out or regulate key genes involved in the formation of TNTs. For example, research has shown that the monomeric form of CCT4 can promote the formation of coarse TNTs enriched with microtubule proteins [131]. Therefore, gene editing tools targeting CCT4 or other regulatory factors, such as Cx43, may precisely regulate the generation and function of TNTs in specific cell types [132]. Discussion and outlook TNTs add a structural dimension to intercellular communication by providing direct physical connectivity between cells and enabling transfer processes that extend beyond classical diffusion-based signaling and EV-mediated delivery [133]. Across neurodegeneration, cancer, cardiovascular injury, and pathogen dissemination, TNT-associated phenomena illustrate how cell collectives can redistribute stress, exchange organelles or informational cargo, and reshape neighboring-cell behavior in a context-dependent manner [48, 134]. In physiological or reparative settings, such communication may contribute to tissue adaptation and metabolic support; in pathological settings, similar routes may be co-opted to promote protein aggregate propagation, immune escape, infection, or treatment resistance. Despite rapid progress, several challenges remain. First, systematic understanding of TNT dynamics, stability, and functional output under in vivo conditions is still limited. Much of the current evidence relies on two-dimensional cultures, endpoint imaging, or TNT-like morphological assignments, which incompletely capture TNT behavior in native microenvironments [39, 135, 136]. Advancing the field will require integration of high-spatiotemporal-resolution live imaging, three-dimensional and tissue-based models, and single-cell or spatial omics approaches to map TNT-associated cellular states, define where and when TNTs form, and link structure to functional transfer in intact tissues [88, 122, 137]. TNT biology is also strongly shaped by cell identity and microenvironment. TNTs formed by different cell types can differ in morphology, stability, cytoskeletal composition, terminal architecture, and transport competence [138, 139]. This heterogeneity complicates attempts to infer universal rules. In the nervous system, TNT-associated transfer may support aggregate handling or mitochondrial rescue in selected contexts, whereas in tumors similar communication routes may reinforce collective survival, metabolic adaptation, and therapy resistance [140]. Future work should therefore avoid treating TNT function as a universal template and instead develop disease- and cell-type-specific regulatory maps that distinguish adaptive from maladaptive TNT-associated events. Translational development faces a central dilemma: TNTs may support physiological repair, yet they can also mediate disease-promoting exchange. Current experimental tools, including broad actin perturbators and cytoskeletal inhibitors, are useful for mechanistic studies but lack selectivity and may interfere with essential cellular processes [141, 142]. A key priority is therefore to identify molecular dependencies preferentially engaged in pathological TNT programs, such as disease-specific signaling nodes, membrane–cytoskeletal scaffolds, or cargo-loading mechanisms [143]. Such targets could allow selective modulation of harmful TNT-mediated transfer while reducing off-target disruption of normal intercellular communication. In parallel, nanotechnology and delivery platforms may offer opportunities for spatially controlled perturbation or TNT-guided therapeutic delivery in defined microenvironments [144]. The expanding toolbox of three-dimensional cultures, organoids, spheroids, and tissue-mimetic systems will be important for bridging reductionist observations and in vivo relevance [43, 145, 146]. These models better recapitulate extracellular matrix topology, mechanical constraints, and multicellular architecture, thereby enabling more faithful assessment of TNT formation, cargo transfer, and functional outcomes. When combined with advanced imaging, pathway-resolved controls, and genetic perturbation, such platforms can help establish causal links between TNT-mediated transfer and disease phenotypes [147]. Looking ahead, the next phase of TNT research should prioritize selective functional modulation rather than indiscriminate inhibition. The central goal is to mitigate disease-associated TNT activities while preserving, or potentially harnessing, beneficial roles in tissue homeostasis and repair. Defining cell-type- and context-specific regulatory circuits will be essential for developing tailored intervention strategies. With continued technological integration and mechanistic refinement, TNTs may evolve from an intriguing cell-biological phenomenon into a tractable axis for translational exploration. Acknowledgments Use of generative AI and AI-assisted technologies During manuscript revision, ChatGPT was used for language polishing, structural editing, and improvement of clarity. The authors reviewed, edited, and verified all scientific content, references, and interpretations, and take full responsibility for the final content of the manuscript. Authors’ contributions Xinyu Dong: Conceptualization, Funding acquisition, Writing – original draft, Formal analysis. Yan Xuan: Investigation, Data curation. Muning Wang: Validation, Visualization. Siyao Chang: Resources, Data curation. Xuesong Hu: Writing – review & editing, Methodology. Zhiyang Han: Supervision, Project administration, Funding acquisition, Writing – review & editing. All authors have read and agreed to the published version of the manuscript. Funding This study was supported by the Special Project on Chronic Disease Management of the National Health Commission Capacity Building and Continuing Education Center (GWJJMB202510021059) and the Provincial Guiding Project of the 2025 Heilongjiang Undergraduate Innovation Training Program (S202510226067). Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable. This is a review article and does not contain any original studies with human participants or animals performed by any of the authors. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.